What does DAG-med do?

DAG-med is a specialist medical practice in Estinnes. Private Limited, started on 24 October 2005.

What is the address of DAG-med?

The registered office of DAG-med is located at Rue Grand-Trieux(EMT) 20A, 7120 Estinnes.

Is DAG-med still active?

Yes. According to the CBE (29 October 2026) DAG-med is active, legal situation “Normale toestand”, started on 24 October 2005.

Is DAG-med registered on Peppol?

Yes, DAG-med is registered on the Peppol network with ID 0208:0876875248.

What is the enterprise number of DAG-med?

The enterprise number of DAG-med is BE0876875248.

When was DAG-med founded?

DAG-med was founded on 24 October 2005.

Who are the directors of DAG-med?

According to the 2025 annual accounts, the directors of DAG-med are: RASVAN-DAN GUSU.

Is DAG-med a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 October 2005; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DAG-med make in 2025?

DAG-med posted a profit after taxes of € 234,650 in financial year 2025.

What is the revenue of DAG-med?

As a small company, DAG-med is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 307,205.

DAG-med (Private Limited) - Estinnes - BE0876875248

Dossier DAG-med, printed on 29 October 2026 from databakkes.be/en/0876875248/dag-med. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DAG-med from Estinnes, company number BE0876875248, closed financial year 2025 with a result of € 234,650 after tax. For that financial year DAG-med recorded a gross margin of € 307,205 and equity of € 2.1 million. Compared with financial year 2024, the result moved from € 241,457 to € 234,650. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What it is worth Growing

€ 2.1 million

▲ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 234,650

▼ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 53,735

▲ 255% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 2.1 million.

People and assets in 2025

Vehicles and equipment

€ 5,912

▼ 29% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 620,971

▼ 15% vs 2024

€ 109,546 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 5,489

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 311,709 Gross margin 2022: € 311,709 First fiscal year in the series	€ 274,545 Gross margin 2023: € 274,545 ▼ 12% vs 2022 (€ 311,709) Unfavourable step	€ 347,804 Gross margin 2024: € 347,804 ▲ 27% vs 2023 (€ 274,545) Favourable step	€ 307,205 Gross margin 2025: € 307,205 ▼ 12% vs 2024 (€ 347,804) Unfavourable step	▼ 12%
Profit after taxes	€ 194,686 Profit after taxes 2022: € 194,686 First fiscal year in the series	€ 182,666 Profit after taxes 2023: € 182,666 ▼ 6% vs 2022 (€ 194,686) Unfavourable step	€ 241,457 Profit after taxes 2024: € 241,457 ▲ 32% vs 2023 (€ 182,666) Favourable step	€ 234,650 Profit after taxes 2025: € 234,650 ▼ 3% vs 2024 (€ 241,457) Unfavourable step	▼ 3%
Equity	€ 1,423,885 Equity 2022: € 1,423,885 First fiscal year in the series	€ 1,606,551 Equity 2023: € 1,606,551 ▲ 13% vs 2022 (€ 1,423,885) Favourable step	€ 1,848,007 Equity 2024: € 1,848,007 ▲ 15% vs 2023 (€ 1,606,551) Favourable step	€ 2,082,657 Equity 2025: € 2,082,657 ▲ 13% vs 2024 (€ 1,848,007) Favourable step	▲ 13%
Total debts	€ 944,465 Total debts 2022: € 944,465 First fiscal year in the series	€ 840,206 Total debts 2023: € 840,206 ▼ 11% vs 2022 (€ 944,465) Favourable step	€ 734,214 Total debts 2024: € 734,214 ▼ 13% vs 2023 (€ 840,206) Favourable step	€ 626,460 Total debts 2025: € 626,460 ▼ 15% vs 2024 (€ 734,214) Favourable step	▼ 15%
Cash	€ 12,045 Cash 2022: € 12,045 First fiscal year in the series	€ 10,958 Cash 2023: € 10,958 ▼ 9% vs 2022 (€ 12,045) Unfavourable step	€ 15,140 Cash 2024: € 15,140 ▲ 38% vs 2023 (€ 10,958) Favourable step	€ 53,735 Cash 2025: € 53,735 ▲ 255% vs 2024 (€ 15,140) Favourable step	▲ 255%
Land & buildings	€ 602,548 Land & buildings 2022: € 602,548 First fiscal year in the series	€ 583,567 Land & buildings 2023: € 583,567 ▼ 3% vs 2022 (€ 602,548) Unchanged	€ 564,587 Land & buildings 2024: € 564,587 ▼ 3% vs 2023 (€ 583,567) Unchanged	€ 545,606 Land & buildings 2025: € 545,606 ▼ 3% vs 2024 (€ 564,587) Unchanged	▼ 3%
Retained profit	€ 1,405,285 Retained profit 2022: € 1,405,285 First fiscal year in the series	€ 1,587,951 Retained profit 2023: € 1,587,951 ▲ 13% vs 2022 (€ 1,405,285) Favourable step	€ 1,829,407 Retained profit 2024: € 1,829,407 ▲ 15% vs 2023 (€ 1,587,951) Favourable step	€ 2,064,057 Retained profit 2025: € 2,064,057 ▲ 13% vs 2024 (€ 1,829,407) Favourable step	▲ 13%
Bank debt	€ 938,976 Bank debt 2022: € 938,976 First fiscal year in the series	€ 834,717 Bank debt 2023: € 834,717 ▼ 11% vs 2022 (€ 938,976) Favourable step	€ 728,725 Bank debt 2024: € 728,725 ▼ 13% vs 2023 (€ 834,717) Favourable step	€ 620,971 Bank debt 2025: € 620,971 ▼ 15% vs 2024 (€ 728,725) Favourable step	▼ 15%
Balance sheet total	€ 2,428,350 Balance sheet total 2022: € 2,428,350 First fiscal year in the series	€ 2,506,757 Balance sheet total 2023: € 2,506,757 ▲ 3% vs 2022 (€ 2,428,350) Unchanged	€ 2,642,222 Balance sheet total 2024: € 2,642,222 ▲ 5% vs 2023 (€ 2,506,757) Unchanged	€ 2,769,117 Balance sheet total 2025: € 2,769,117 ▲ 5% vs 2024 (€ 2,642,222) Unchanged	▲ 5%

Key figures of DAG-med, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DAG-med?

What happened at DAG-med in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2026 New annual accounts for financial year 2025: profit of € 234,650 (▼ 3% vs 2024). Source: NBB ↗
Oct 24, 2005 Start of the company according to the CBE. KBO

In short

From € 194,686 profit in 2022 to € 234,650 profit in 2025.

Paid € 202,110 in corporate taxes since 2022.

Best year ever: 2024, with € 241,457 profit.

Original PDFs at the National Bank ↗

Management

RASVAN-DAN GUSU

DAG-med

Behind DAG-med is RASVAN-DAN GUSU.

Directors

According to the 2025 annual accounts

RASVAN-DAN GUSU

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Grand-Trieux(EMT) 20A

7120 Estinnes

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0876.875.248
VAT number: BE 0876.875.248
Registered office: Rue Grand-Trieux(EMT) 20A, 7120 Estinnes
Names & denominations: DAG-med
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 October 2005
Peppol: Active · Active since 19 Sept 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗